HSP27/HSPB1 as an adaptive podocyte antiapoptotic protein activated by high glucose and angiotensin II

Laboratory Investigation

Volumn 92, Issue 1, 2012, Pages 32-45

  Sanchez Nĩo, Maria D ^a   Sanz, Ana B ^b   Sanchez Lopez, Elsa ^c   Ruiz Ortega, Marta ^d   Benito Martin, Alberto ^a   Saleem, Moin A ^e   Mathieson, Peter W ^e   Mezzano, Sergio ^f   Egido, Jesus ^a,d,g   Ortiz, Alberto ^a,d,g  

^a 28400 Madrid   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

^f UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^g Grupo de Estudios Peritoneales de Madrid de REDinREN   (Spain)

Author keywords

apoptosis; diabetes; HSP27; kidney; podocytes

Indexed keywords

ANGIOTENSIN II; CASPASE; HEAT SHOCK PROTEIN 27; MESSENGER RNA; SMALL INTERFERING RNA; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS; GLUCOSE INTAKE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY CELL CULTURE; MALE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS REGULATION; RAT; STREPTOZOCIN DIABETES;

EID: 84855221098     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2011.138     Document Type: Article

References (68)

1. Adeghate E. Molecular and cellular basis of the aetiology and management of diabetic cardiomyopathy: a short review. Mol Cell Biochem 2004;261:187-191. (Pubitemid 39004531)
2. Kowluru RA. Diabetic retinopathy: mitochondrial dysfunction and retinal capillary cell death. Antioxid Redox Signal 2005;7:1581-1587. (Pubitemid 41767993)
3. Ortiz A, Ziyadeh FN, Neilson EG. Expression of apoptosis-regulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidneys. J Investig Med 1997;45: 50-56. (Pubitemid 127453337)
4. Jefferson JA, Shankland SJ, Pichler RH. Proteinuria in diabetic kidney disease: a mechanistic viewpoint. Kidney Int 2008;74:22-36. (Pubitemid 351841893)
5. Sanchez-Nino MD, Sanz AB, Ihalmo P, et al. The MIF receptor CD74 in diabetic podocyte injury. J Am Soc Nephrol 2009;20:353-362.
6. Reddy GR, Kotlyarevska K, Ransom RF, et al. The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy? Curr Opin Nephrol Hypertens 2008;17:32-36. (Pubitemid 350295194)
7. Wolf G, Chen S, Ziyadeh FN. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 2005;54:1626-1634. (Pubitemid 40770751)
8. Steffes MW, Schmidt D, McCrery R, et al. Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int 2001; 59:2104-2113. (Pubitemid 32467602)
9. Sieber J, Lindenmeyer MT, Kampe K, et al. Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids. Am J Physiol Renal Physiol 2010;299:F821-F829.
10. Sanchez-Nino MD, Benito-Martin A, Ortiz A. New paradigms in cell death in human diabetic nephropathy. Kidney Int 2010;78:737-744.
11. Spurney RF, Coffman TM. Stressed-out podocytes in diabetes? J Am Soc Nephrol 2008;19:2035-2037.
12. Niranjan T, Bielesz B, Gruenwald A, et al. The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med 2008;14:290-298. (Pubitemid 351347919)
13. Susztak K, Raff AC, Schiffer M, et al. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006;55:225-233. (Pubitemid 43343319)
14. Verzola D, Gandolfo MT, Ferrario F, et al. Apoptosis in the kidneys of patients with type II diabetic nephropathy. Kidney Int 2007;72: 1262-1272. (Pubitemid 350059668)
15. Xu ZG, Miao LN, Cui YC, et al. Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli. Nephrol Dial Transplant 2009;24:1744-1752.
16. Ruster C, Bondeva T, Franke S, et al. Angiotensin II upregulates RAGE expression on podocytes: role of AT2 receptors. Am J Nephrol 2009;29:538-550.
17. Sharma M, Sharma R, Greene AS, et al. Documentation of angiotensin II receptors in glomerular epithelial cells. Am J Physiol 1998;274: F623-F627.
18. Ding G, Reddy K, Kapasi AA, et al. Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am J Physiol Renal Physiol 2002;283:F173-F180. (Pubitemid 34680484)
19. Jia J, Ding G, Zhu J, et al. Angiotensin II infusion induces nephrin expression changes and podocyte apoptosis. Am J Nephrol 2008;28:500-507. (Pubitemid 351501616)
20. Zhang H, Ding J, Fan Q, et al. TRPC6 up-regulation in Ang II-induced podocyte apoptosis might result from ERK activation and NF-kappaB translocation. Exp Biol Med (Maywood) 2009;234:1029-1036.
21. Aufricht C, Ardito T, Thulin G, et al. Heat-shock protein 25 induction and redistribution during actin reorganization after renal ischemia. Am J Physiol 1998;274:F215-F222.
22. Kim HP, Morse D, Choi AM. Heat-shock proteins: new keys to the development of cytoprotective therapies. Expert Opin Ther Targets 2006;10:759-769. (Pubitemid 44479983)
23. Fink AL. Chaperone-mediated protein folding. Physiol Rev 1999;79: 425-449. (Pubitemid 29210927)
24. Arrigo AP. sHsp as novel regulators of programmed cell death and tumorigenicity. Pathol Biol (Paris) 2000;48:280-288. (Pubitemid 30318128)
25. Ferns G, Shams S, Shafi S. Heat shock protein 27: its potential role in vascular disease. Int J Exp Pathol 2006;87:253-274. (Pubitemid 44049960)
26. Lavoie JN, Lambert H, Hickey E, et al. Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation- induced changes in the oligomeric structure of heat shock protein 27. Mol Cell Biol 1995;15:505-516. (Pubitemid 24379949)
27. Vertii A, Hakim C, Kotlyarov A, et al. Analysis of properties of small heat shock protein Hsp25 in MAPK-activated protein kinase 2 (MK2)- deficient cells: MK2-dependent insolubilization of Hsp25 oligomers correlates with susceptibility to stress. J Biol Chem 2006;281: 26966-26975. (Pubitemid 44401725)
28. Garrido C, Bruey JM, Fromentin A, et al. HSP27 inhibits cytochrome cdependent activation of procaspase-9. FASEB J 1999;13:2061-2070. (Pubitemid 29517636)
29. Jaattela M. Overexpression of major heat shock protein hsp70 inhibits tumor necrosis factor-induced activation of phospholipase A2. J Immunol 1993;151:4286-4294. (Pubitemid 23298762)
30. Bruey JM, Ducasse C, Bonniaud P, et al. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol 2000;2:645-652.
31. Smoyer WE, Gupta A, Mundel P, et al. Altered expression of glomerular heat shock protein 27 in experimental nephrotic syndrome. J Clin Invest 1996;97:2697-2704. (Pubitemid 26197714)
32. Saleem MA, O'Hare MJ, Reiser J, et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 2002;13:630-638. (Pubitemid 34183927)
33. Sanchez-Nino MD, Sanz AB, Lorz C, et al. BASP1 promotes apoptosis in diabetic nephropathy. J Am Soc Nephrol 2010;21:610-621.
34. Lorz C, Benito-Martin A, Boucherot A, et al. The death ligand TRAIL in diabetic nephropathy. J Am Soc Nephrol 2008;19:904-914.
35. Sanz AB, Justo P, Sanchez-Nino MD, et al. The cytokine TWEAK modulates renal tubulointerstitial inflammation. J Am Soc Nephrol 2008;19:695-703.
36. Justo P, Sanz AB, Egido J, et al. 3,4-Dideoxyglucosone-3-ene induces apoptosis in renal tubular epithelial cells. Diabetes 2005;54:2424-2429. (Pubitemid 41134271)
37. Catalan MP, Reyero A, Egido J, et al. Acceleration of neutrophil apoptosis by glucose-containing peritoneal dialysis solutions: role of caspases. J Am Soc Nephrol 2001;12:2442-2449. (Pubitemid 33021122)
38. Catalan MP, Santamaria B, Reyero A, et al. 3,4-di-deoxyglucosone-3-ene promotes leukocyte apoptosis. Kidney Int 2005;68:1303-1311. (Pubitemid 43246451)
39. Catalan MP, Esteban J, Subira D, et al. Inhibition of caspases improves bacterial clearance in experimental peritonitis. Perit Dial Int 2003;23:123-126. (Pubitemid 36410852)
40. Carvajal G, Rodriguez-Vita J, Rodrigues-Diez R, et al. Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation. Kidney Int 2008;74:585-595.
41. Ruiz-Ortega M, Lorenzo O, Ruperez M, et al. Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP- 1 in the kidney: role of AT(1) and AT(2) receptors. Am J Pathol 2001;158:1743-1756. (Pubitemid 32422939)
42. Ruperez M, Ruiz-Ortega M, Esteban V, et al. Angiotensin II increases connective tissue growth factor in the kidney. Am J Pathol 2003;163:1937-1947. (Pubitemid 37310024)
43. Snoeckx LH, Cornelussen RN, Van Nieuwenhoven FA, et al. Heat shock proteins and cardiovascular pathophysiology. Physiol Rev 2001;81:1461-1497. (Pubitemid 32947777)
44. Sanz AB, Santamaria B, Ruiz-Ortega M, et al. Mechanisms of renal apoptosis in health and disease. J Am Soc Nephrol 2008;19: 1634-1642.
45. Mehlen P, Briolay J, Smith L, et al. Analysis of the resistance to heat and hydrogen peroxide stresses in COS cells transiently expressing wild type or deletion mutants of the Drosophila 27-kDa heat-shock protein. Eur J Biochem 1993;215:277-284. (Pubitemid 23224310)
46. Mehlen P, Schulze-Osthoff K, Arrigo AP. Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1- and staurosporine-induced cell death. J Biol Chem 1996;271: 16510-16514. (Pubitemid 26239003)
47. Oesterreich S, Weng CN, Qiu M, et al. The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines. Cancer Res 1993;53:4443-4448. (Pubitemid 23304358)
48. Bruey JM, Paul C, Fromentin A, et al. Differential regulation of HSP27 oligomerization in tumor cells grown in vitro and in vivo. Oncogene 2000;19:4855-4863.
49. Charette SJ, Landry J. The interaction of HSP27 with Daxx identifies a potential regulatory role of HSP27 in Fas-induced apoptosis. Ann N Y Acad Sci 2000;926:126-131. (Pubitemid 32050150)
50. Paul C, Simon S, Gibert B, et al. Dynamic processes that reflect antiapoptotic strategies set up by HspB1 (Hsp27). Exp Cell Res 2010;316:1535-1552.
51. Havasi A, Li Z, Wang Z, et al. Hsp27 inhibits Bax activation and apoptosis via a phosphatidylinositol 3-kinase-dependent mechanism. J Biol Chem 2008;283:12305-12313.
52. Liu JJ, Ma X, Cai LB, et al. Downregulation of both gene expression and activity of Hsp27 improved maturation of mouse oocyte in vitro. Reprod Biol Endocrinol 2010;8:47.
53. Wharram BL, Goyal M, Wiggins JE, et al. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 2005;16:2941-2952. (Pubitemid 44743492)
54. Hoffmann S, Podlich D, Hahnel B, et al. Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. J Am Soc Nephrol 2004;15:1475-1487. (Pubitemid 38679672)
55. Dai T, Natarajan R, Nast CC, et al. Glucose and diabetes: effects on podocyte and glomerular p38MAPK, heat shock protein 25, and actin cytoskeleton. Kidney Int 2006;69:806-814.
56. Kostenko S, Moens U. Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology. Cell Mol Life Sci 2009;66: 3289-3307.
57. Barutta F, Pinach S, Giunti S, et al. Heat shock protein expression in diabetic nephropathy. Am J Physiol Renal Physiol 2008;295: F1817-F1824.
58. Park JK, Ronkina N, Höft A, et al. Deletion of MK2 signalling in vivo inhibits small Hsp phosphorylation but not diabetic nephropathy. Nephrol Dial Transplant 2008;23:1844-1853. (Pubitemid 351768165)
59. Bryantsev AL, Chechenova MB, Shelden EA. Recruitment of phosphorylated small heat shock protein Hsp27 to nuclear speckles without stress. Exp Cell Res 2007;313:195-209. (Pubitemid 44958463)
60. Hollander JM, Martin JL, Belke DD, et al. Overexpression of wild-type heat shock protein 27 and a nonphosphorylatable heat shock protein 27 mutant protects against ischemia/reperfusion injury in a transgenic mouse model. Circulation 2004;110:3544-3552. (Pubitemid 39612569)
61. de Graauw M, Tijdens I, Cramer R, et al. Heat shock protein 27 is the major differentially phosphorylated protein involved in renal epithelial cellular stress response and controls focal adhesion organization and apoptosis. J Biol Chem 2005;280:29885-29898. (Pubitemid 41177066)
62. Aoudjit L, Stanciu M, Li H, et al. p38 mitogen-activated protein kinase protects glomerular epithelial cells from complementmediated cell injury. Am J Physiol Renal Physiol 2003;285: F765-F774. (Pubitemid 37140260)
63. Smoyer WE, Ransom R, Harris RC, et al. Ischemic acute renal failure induces differential expression of small heat shock proteins. J Am Soc Nephrol 2000;11:211-221. (Pubitemid 30064844)
64. Smoyer WE, Ransom RF. Hsp27 regulates podocyte cytoskeletal changes in an in vitro model of podocyte process retraction. FASEB J 2002;16:315-326. (Pubitemid 34195293)
65. Benigni A, Gagliardini E, Remuzzi G. Changes in glomerular permselectivity induced by angiotensin II imply podocyte dysfunction and slit diaphragm protein rearrangement. Semin Nephrol 2004; 24:131-140. (Pubitemid 38387854)
66. Macconi D, Bonomelli M, Benigni A, et al. Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury. Am J Pathol 2006;168:42-54. (Pubitemid 43062558)
67. Ishizaka N, Aizawa T, Ohno M, et al. Regulation and localization of HSP70 and HSP25 in the kidney of rats undergoing long-term administration of angiotensin II. Hypertension 2002;39:122-128. (Pubitemid 34098100)
68. Navarro JF, Milena FJ, Mora C, et al. Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensinconverting enzyme inhibition and pentoxifylline administration. Am J Nephrol 2006;26:562-570. (Pubitemid 46143878)